Aromatherapy scent diffusion for mild cognitive impairment and mild dementia symptoms
Tests diffused essential oil scents in people with mild cognitive impairment or mild dementia.
Key facts
- Who runs it
- National Cancer Centre, Singapore
- Where
- Singapore2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 9 Jun 2026
- Expected to end
- Nov 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Aromatherapy
- Record updated
- 17 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 50 and above with mild cognitive impairment (MCI) or mild dementia, together with their caregiver. It tests whether breathing in a diffused essential oil blend (aromatherapy) helps symptoms and caregiver stress.
- Age
- Patients: 50 Years to 99 Years. Caregivers: 21 years and above.
- Sex
- All sexes can join.
- Disease stage
- A confirmed diagnosis of MCI or mild dementia in the clinical records.
Main reasons for not taking part
- Poor or lost sense of smell.
- Known or suspected allergy to essential oils or any part of the formulations.
- Reactive Airway Disease, such as asthma.
- No caregiver who lives with the patient or sees them for ≥2 hours/day ≥3 days/week and comes to each study visit.
- Pregnant, breastfeeding, or planning a pregnancy during the study.
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- For patients:
- Aged 50 years old and above
- Confirmed diagnosis of MCI or mild dementia based on clinical records
- Has one identified caregiver aged 21 years and above who is willing to provide written informed consent for his/her own participation; is able to read, understand, and speak the designated language at the study site; either lives with the subject or sees the subject for ≥2 hours/day ≥3 days/week; agrees to accompany the subject to each study visit; and is able to verify daily compliance with study intervention; For caregivers:
- Aged 21 years old and above
- Willing and able to provide written informed consent
- Identified as the caregiver for recruited patient in this study can read, understand, and speak the designated language at the study site; either lives with the recruited patients or sees the patient for ≥2 hours/day ≥3 days/week
- Agrees to accompany the patient to each study visit; and can verify daily compliance with study intervention
Who cannot take part
- Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations
- Has Reactive Airway Disease (e.g, Asthma)
- For patients:
- Olfactory impaired/dysfunctional
- Participant without a caregiver
- Pregnant, breastfeeding, or intending to conceive during study period; For caregivers:
- Physically or mentally incapable of providing verbal / written consent
- Does not have regular or meaningful contact with the participant (e.g. less than 2 hours/day or less than 3 days/week)
- Not able to follow patient to each study visit
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 50 and 99 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To determine if diffusion aromatherapy exposure to an essential oil blend can potentially improve mild cognitive impairment/mild dementia symptoms and relieve caregiver stress.
Read full original descriptionShow less
This study also allows us to gauge the willingness of elderly patients in complying with long-term aromatherapy treatments.
The 2 groups in the trial
- Control GroupTreatment being tested
- Intervention GroupTreatment being tested
Treatment: Aromatherapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia (SENSE)
- Plain-language title
- Aromatherapy scent diffusion for mild cognitive impairment and mild dementia symptomsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT07234357, who can take part
- Record updated
- 17 July 2026